Contraception

Trump Administration Finalizes Birth Control Coverage Opt-Out

Trump Administration Finalizes Birth Control Coverage Opt-Out

A birth control coverage opt-out for employers was finalized by the Trump administration on Wednesday.

Liletta Now Approved for Pregnancy Prevention for Up to 5 Years

Liletta Now Approved for Pregnancy Prevention for Up to 5 Years

By

The expanded approval was supposed by safety and efficacy data from the Phase 3 ACCESS IUS trial (N=1751) in women receiving Liletta. In the trial, Liletta demonstrated >99% efficacy in preventing pregnancy for up to 5 years in a broad patient population.

Continuous or extended combined oral contraceptive regimens not linked to higher venous thromboembolism risk

In this retrospective cohort study, continuous (84/7) or extended (365/0) cycle regimens of combined oral contraceptives were not linked with meaningfully higher rates of venous thromboembolism when compared with traditional cyclic (21/7) regimens.

Newer Hormonal Contraception May Cut Ovarian Cancer Risk

Newer Hormonal Contraception May Cut Ovarian Cancer Risk

Combined hormonal contraception use tied to lower risk; risk down with increasing duration of use.

Recent Increase in Contraception Use Noted Among US Teenagers

Recent Increase in Contraception Use Noted Among US Teenagers

Increases in use of 1 or more contraceptive methods, dual-method use, long-acting reversibles.

Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?

Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?

Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.

Assessing a Comprehensive Long-Acting Reversible Contraceptive Program

Assessing a Comprehensive Long-Acting Reversible Contraceptive Program

By

An evaluation assessed the nonhealthcare-related influences that have led to misconceptions about long-acting reversible contraceptives.

Number of IUD Insertions Increases After ACA Contraceptive Mandate

Number of IUD Insertions Increases After ACA Contraceptive Mandate

Increase in use depends on the amount of reduction in out-of-pocket costs

Long-acting reversible contraceptives: a review

Long-acting reversible contraceptives: a review

Because of the high number of unintended pregnancies and the effectiveness of LARCs, they should be a first-line contraceptive option for most women.

Hormonal contraception use linked to an increased risk of breast cancer

Hormonal contraception use linked to an increased risk of breast cancer

By

Breast cancer diagnosis is higher among women who currently use or recently used contemporary hormonal contraceptives than among women who have never used hormonal contraceptives.

CDC updates contraception recommendations for women at risk for HIV

CDC updates contraception recommendations for women at risk for HIV

The CDC revised its US Medical Eligibility Criteria for Contraceptive Use categorization for DMPA injection in women at high risk for HIV infection from US MEC category 1 to US MEC category 2.

ACOG issues recommendations for long-acting reversible contraception

ACOG issues recommendations for long-acting reversible contraception

By

The practice bulletin provides information for appropriate patient selection and evidence-based recommendations for intrauterine devices and contraceptive implants.

Oral contraceptives may be protective against some types of cancer

Oral contraceptives may be protective against some types of cancer

By

Use of oral contraceptives did not increase the risk for cancer in women and decreased the risk for colorectal, endometrial, ovarian, and lymphatic and hematopoietic cancers.

Long-acting reversible contraception effective in nulliparous adolescents

Long-acting reversible contraception effective in nulliparous adolescents

By

LARC is safe and effective in nulliparous adolescents and should be considered as a viable alternative to oral contraception.

Oral contraceptives increase surgery risk for women with Crohn disease

Oral contraceptives increase surgery risk for women with Crohn disease

By

Women with Crohn disease who use oral contraceptives for more than 1 year have an increased risk of surgery.

Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives

Levonorgestrel, low-dose estrogen associated with lower risk for adverse vascular events among oral contraceptives

By

Compared with other estrogen doses and progestogen types, low-dose estrogen with levonorgestrel had a decreased risk of adverse events.

What in the world is Vasalgel?

What in the world is Vasalgel?

By

A form of male birth control called Vasalgel, which works by injecting a polymer gel into the vas deferens, is being developed in the United States.

FDA to require Black Box warning for Essure birth control device

FDA to require Black Box warning for Essure birth control device

By

The agency will require Bayer to conduct clinical studies examining the device's benefits and harms.

More reader comments on ethical issues regarding use of IUDs

More reader comments on ethical issues regarding use of IUDs

More readers weigh in on the ethical issues surrounding the use of intrauterine devices.

Oregon becomes first state to offer birth control without a prescription

Oregon becomes first state to offer birth control without a prescription

Starting January 1, the state of Oregon no longer requires a prescription for birth control for women 18 years of age and older.

Ethical concerns with IUDs


Ethical concerns with IUDs


For women who are pro-life advocates, copper IUD devices that prevent fertilization may be an acceptable alternative.

More Medicaid plans are now 
covering post-delivery IUDs

More Medicaid plans are now 
covering post-delivery IUDs

By

Expanding Medicaid coverage will allow more low-income women the choice to get an IUD implant immediately after birth.

More Medicaid plans covering post-delivery IUDs

More Medicaid plans covering post-delivery IUDs

By

More Medicaid plans are offering reimbursement for women who choose to get long-term contraception implants immediately after giving birth.

The IUD rumor mill: Common misconceptions

The IUD rumor mill: Common misconceptions

Disseminating accurate information can help women make informed decisions and potentially increase the overall use of intrauterine devices.

Obesity linked to lower contraception use in teen girls

Obesity linked to lower contraception use in teen girls

Although they have sex with the same frequency as other girls, obese teens are less likely to use contraception.

Newer contraceptive pills may have higher clot risks

Newer contraceptive pills may have higher clot risks

By

Women taking contraceptive pills that contain newer types of progestogen have higher clot risks.

Debunking contraception myths may lower unplanned pregnancy rates

Debunking contraception myths may lower unplanned pregnancy rates

Nearly 87 million women face an unplanned pregnancy due to the underuse of contraception each year,.

Recommendations for improving access to contraception issued

Recommendations for improving access to contraception issued

Barriers include knowledge deficits, cost and insurance coverage, unnecessary medical testing.

IUDs, implants gaining popularity

IUDs, implants gaining popularity

The pill is still the most popular birth control method of choice.

Many insurers still don't cover long-term birth control

Many insurers still don't cover long-term birth control

Nearly 40% of women do not have access to free long-acting contraceptives.

Sign Up for Free e-newsletters